http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1799946_PMID

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038957_AID1799946_PMID_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038959_AID1799946_PMID_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038960_AID1799946_PMID_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038955_AID1799946_PMID_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038956_AID1799946_PMID_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038954_AID1799946_PMID_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038958_AID1799946_PMID_VALUE5
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41146
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title ORL-1 Receptor Binding Assay from US Patent US8476271: \"Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators\"
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038957
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1799946

Total number of triples: 19.